Merger: absorbed by MULTIPHARMA
Dissolution of the company · Dissolved without liquidation · MULTIPHARMA holds all the shares · General meeting of 13-06-2019 · Gazette deed
Merger proposal: to be absorbed by MULTIPHARMA
Gazette deed
Registered office moved from Brussels to Anderlecht
The registered office moved from Rue de Veeweyde, 6-1070 Bruxelles to Square Marie Curie 30-1070 Anderlecht · Name after signing inVisible after signing in (managing director) and Name hiddenVisible after signing in (director) resign · Hidden nameVisible after signing in (chair of the board), Name after signing inVisible after signing in (managing director), Name hiddenVisible after signing in and Hidden nameVisible after signing in (statutory auditor) appointed · General meeting of 22-05-2017 · Gazette deed
Amendment of the articles
General meeting of 03-11-2016 · Gazette deed
Absorbed by MULTIPHARMAmerger by absorption, March 2019
Activity
“De faire pour son compte ou pour compte d'autrui, toutes opérations se rapportant directement…” (deed in French)From the articles, 7 activitiesNo NACE code in the KBO
The turnover in financial year 2018 is about €150,000. This figure is estimated from the gross margin of €42,436 and 888 comparable companies of the same size. It probably lies between €81,000 and €310,000. It is a rough estimate.Financials
Is BECOFAR profitable?
In financial year 2018, BECOFAR made a profit of €222,533.
Where can I find the annual accounts of BECOFAR?
BECOFAR filed 30 annual accounts with the National Bank of Belgium, the latest for financial year 2018.